Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

Sangamo enters agreement with Zeneca for identification of novel gene targets

Nov. 10, 1998

MitoKor and Pfizer to collaborate on mitochondrial targets for neurodegenerative diseases

Nov. 10, 1998

Corixa invests in, works with ImmGenics to develop high-potency monoclonal antibodies

Nov. 9, 1998

Dutch research group focuses attention on adenosine A3 receptor ligands

Nov. 5, 1998

Step taken toward European protection for AltaRex's fundamental technology platform

Nov. 5, 1998

GenVec receives expanded patent coverage in field of gene therapy

Nov. 4, 1998

New agreement between Pharmacopeia and Schering-Plough expands R&D collaboration

Nov. 4, 1998

Aastrom awarded second NIH grant to develop production system for UCB stem cells

Nov. 3, 1998

ArQule, Roche Bioscience amend R&D agreement

Nov. 3, 1998

Targeted Genetics receives patent coverage for cellular therapy platform

Nov. 2, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 23, 2026.
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
KBN-2201 reverses key features of Alzheimer’s in mice
BioWorld Science
Researchers from Ajou University School of Medicine reported the preclinical efficacy of KBN-2201 in a mouse model of late-stage Alzheimer’s disease.
In vivo click ADCs could address tumor heterogeneity
BioWorld
Researchers at Washington University in St. Louis have used click chemistry to link a second antibody to a pre-existing antibody-drug conjugate (ADC) in vivo. In...